Ftse Mib
33.772,39
-0,04%
DAX
19.884,75
-0,57%
S&P 500
5.945,78
1,34%
NASDAQ
19.673,10
1,55%
Bitcoin
97.039,81
-0,43%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Sophia Genetics SA (SOPH) Sophia Genetics SA (SOPH) Notizie

Sophia Genetics SA

SOPH
3,17
0,07 (2,26%)
Ultimo aggiornamento: 19:57:36
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
19/12/202422:19EDGAR2Form 144 - Report of proposed sale of securities
19/12/202422:19EDGAR2Form 144 - Report of proposed sale of securities
13/12/202422:27EDGAR2Form 144 - Report of proposed sale of securities
21/11/202411:30PRNUSSOPHiA GENETICS Launches MSK-IMPACT® powered with SOPHiA..
19/11/202420:52EDGAR2Form 144 - Report of proposed sale of securities
19/11/202420:50EDGAR2Form 144 - Report of proposed sale of securities
19/11/202420:49EDGAR2Form 144 - Report of proposed sale of securities
19/11/202420:48EDGAR2Form 144 - Report of proposed sale of securities
19/11/202420:46EDGAR2Form 144 - Report of proposed sale of securities
19/11/202420:45EDGAR2Form 144 - Report of proposed sale of securities
06/11/202413:00PRNUSSOPHiA GENETICS and Genomenon Collaborate to Streamline..
05/11/202412:39EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/11/202412:38EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and..
05/11/202412:32PRNUSSOPHiA GENETICS Promotes Ross Muken to President and..
05/11/202412:30PRNUSSOPHiA GENETICS Reports Third Quarter 2024 Results
23/10/202403:17EDGAR2Form 144 - Report of proposed sale of securities
23/10/202403:17EDGAR2Form 144 - Report of proposed sale of securities
23/10/202403:17EDGAR2Form 144 - Report of proposed sale of securities
23/10/202403:17EDGAR2Form 144 - Report of proposed sale of securities
23/10/202403:16EDGAR2Form 144 - Report of proposed sale of securities
23/10/202403:16EDGAR2Form 144 - Report of proposed sale of securities
22/10/202412:45PRNUSSOPHiA GENETICS to Announce Financial Results for Third..
04/10/202421:44EDGAR2Form 144 - Report of proposed sale of securities
04/10/202421:43EDGAR2Form 144 - Report of proposed sale of securities
04/10/202421:42EDGAR2Form 144 - Report of proposed sale of securities
04/10/202421:41EDGAR2Form 144 - Report of proposed sale of securities
04/10/202421:40EDGAR2Form 144 - Report of proposed sale of securities
04/10/202421:38EDGAR2Form 144 - Report of proposed sale of securities
20/9/202403:31EDGAR2Form 144 - Report of proposed sale of securities
20/9/202403:31EDGAR2Form 144 - Report of proposed sale of securities
20/9/202403:31EDGAR2Form 144 - Report of proposed sale of securities
20/9/202403:30EDGAR2Form 144 - Report of proposed sale of securities
20/9/202403:30EDGAR2Form 144 - Report of proposed sale of securities
20/9/202403:30EDGAR2Form 144 - Report of proposed sale of securities
14/9/202415:00PRNUSSOPHiA GENETICS Presents Ground-Breaking Multimodal Research..
13/9/202422:21EDGAR2Form 144 - Report of proposed sale of securities
12/9/202413:00PRNUSSOPHiA GENETICS Announces Poster Presentations at ESMO 2024
12/9/202410:00PRNUSSOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO..
10/9/202416:28PRNUSSOPHiA GENETICS and AstraZeneca Collaborate to Further..
10/9/202416:16PRNUSSOPHiA GENETICS and AstraZeneca Collaborate to Further..
05/9/202414:30PRNUSSOPHiA GENETICS Announces Validation of Novel Clinical Trial..
04/9/202412:00PRNUSSOPHiA GENETICS Unveils New Generation of the SOPHiA DDMTM..
28/8/202419:30PRNUSSOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley..
20/8/202403:07EDGAR2Form 144 - Report of proposed sale of securities
20/8/202403:07EDGAR2Form 144 - Report of proposed sale of securities
20/8/202403:06EDGAR2Form 144 - Report of proposed sale of securities
20/8/202403:06EDGAR2Form 144 - Report of proposed sale of securities
20/8/202403:06EDGAR2Form 144 - Report of proposed sale of securities
20/8/202403:06EDGAR2Form 144 - Report of proposed sale of securities
14/8/202409:00PRNUSSOPHiA DDM™ Platform Certified Under IVDR
Apertura: 3,19 Min: 3,16 Max: 3,31
Chiusura: 3,10

La tua Cronologia

NASDAQ
SOPH
Sophia Genetics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network